Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00695422 · ClinicalTrials.gov registry record
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- 47
- Enrollment target
NCT00695422 is a clinical trial that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 47 participants.
The verdict
NCT00695422 has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as anal swab collection, digital rectal examination, and anal endoscopy and biopsy, may help find and diagnose anal and genital human papillomavirus infection and squamous intraepithelial lesions and help doctors plan better treatment. PURPOSE: This clinical trial is studying ways to detect anal and genital human papillomavirus infection and squamous intraepithelial lesions in HIV-positive patients enrolled in an AIDS cancer clinical trial.
Interventions
- OTHER cytology specimen collection procedure
- GENETIC polymerase chain reaction
- PROCEDURE colposcopic biopsy
- OTHER histological technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2008-05-14 |
| Est. Completion | 2017-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00695422
The ClinicalTrials.gov registry entry for NCT00695422 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which cytology specimen collection procedure is the first listed.
NCT00695422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00695422 about?
NCT00695422 is a clinical study titled "Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials". RATIONALE: Diagnostic procedures, such as anal swab collection, digital rectal examination, and anal endoscopy and biopsy, may help find and diagnose anal and genital human papillomavirus infection and squamous intraepithelial lesions and help doctors plan better treatment. PURPOSE: This clinical t...
What is the current status of trial NCT00695422?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2008-05-14. Estimated completion is 2017-04-19.
What interventions are being tested in trial NCT00695422?
The interventions under investigation include: cytology specimen collection procedure (OTHER), polymerase chain reaction (GENETIC), colposcopic biopsy (PROCEDURE), histological technique (OTHER).
Who is sponsoring clinical trial NCT00695422?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.